Dr. Ana Corregidor, MD
What this data tells you about Dr. Corregidor
Dr. Ana Corregidor is a gastroenterology in Jacksonville, FL, with 20 years in practice. Based on federal Medicare data, Dr. Corregidor performed 18,521 Medicare services across 1,173 unique beneficiaries.
Between the years covered by Open Payments, Dr. Corregidor received a total of $47,795 from 36 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Corregidor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) | 14,400 | $17 | $34 |
| Infliximab infusion (Remicade) | 2,700 | $26 | $125 |
| Office visit, established patient (30-39 min) | 291 | $90 | $275 |
| Infusion, normal saline solution, 250 cc | 182 | $1 | $122 |
| Colonoscopy with biopsy | 168 | $139 | $850 |
| Office visit, established patient (20-29 min) | 124 | $65 | $200 |
| Administration of chemotherapy into vein, 1 hour or less | 104 | $99 | $425 |
| Upper GI endoscopy with biopsy | 86 | $76 | $650 |
| New patient office visit (45-59 min) | 78 | $117 | $400 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 55 | $216 | $1,214 |
| Administration of chemotherapy into vein, each additional hour | 50 | $22 | $102 |
| Initial hospital admission, moderate complexity | 49 | $102 | $300 |
| Hospital follow-up visit, moderate complexity | 48 | $64 | $200 |
| New patient office visit (30-44 min) | 44 | $73 | $300 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 41 | $4 | $25 |
| Injection, diphenhydramine hcl, up to 50 mg | 32 | $1 | $25 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $181 | $786 |
| New patient office or other outpatient visit, 15-29 minutes | 20 | $54 | $200 |
| Hospital follow-up visit, low complexity | 14 | $41 | $100 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $187 | $800 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for gastroenterology in FL.
Geographic Context
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Corregidor is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 4%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Corregidor experienced with vedolizumab infusion (entyvio)?
Does Dr. Corregidor receive payments from pharmaceutical companies?
How do Dr. Corregidor's costs compare to other gastroenterologys in Jacksonville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology